Serological Study of the Exposure of Personnel to COVID-19 (SEROPHUGAC)

C

Centre Hospitalier Saint Joseph Saint Luc de Lyon

Status

Completed

Conditions

Sars-CoV2

Treatments

Diagnostic Test: Sars-Cov-2 serology

Study type

Interventional

Funder types

Other

Identifiers

NCT04422977
SEROPHUGAC

Details and patient eligibility

About

A seroconversion test for SARS-Cov-2 will be offered to all the employees of a care institution, which has treated 240 patients hospitalized for COVID disease between 28/02 and 30/04/2020. The seroconversion test will be with a questionnaire to determine: * whether the subject has shown signs of infection in the last 3 recent months * if the subject has been in contact with COVID-diagnosed subjects (RT-PCR diagnosis or scanner) outside of the activity or within the professional activity (patient or colleague) * Working conditions during the period * The level of knowledge and respect of the barrier measures practices. * Respect for distance during meals professional. Overall seroprevalence and stratified seroprevalence by care and administrative areas will be determined.

Enrollment

957 patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Subject who worked at Saint Joseph Saint Luke's Hospital during the epidemic wave (male or female).

    • Free and informed consent
    • Social security affiliation

Exclusion criteria

  • Subject refusal
  • Subject on leave during the entire period

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

957 participants in 1 patient group

CoVID exposure
Other group
Treatment:
Diagnostic Test: Sars-Cov-2 serology

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems